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Abstract
Objective
To determine the efficacy and safety of nonpharmacologic interventions for orthostatic hy-
potension (OH) secondary to aging.
Methods
A total of 150 orthostatic challenges were performed in 25 older people (age 60–92 years) to
determine cardiovascular responses to bolus water drinking, compression stockings, abdominal
compression, and physical countermaneuvers. Primary outcome was response rate as assessed
by proportion of participants whose systolic blood pressure (SBP) drop improved by ≥10 mm
Hg.
Results
The response rate to bolus water drinking was 56% (95% confidence interval [CI] 36.7–74.2),
with standing SBP increasing by 12 mm Hg (95% CI 4–20). Physical countermaneuvers were
efficacious in 44% (95%CI 25.8–63.3) but had little effect on standing SBP (+7.5 mmHg [95%
CI −1 to 16]). Abdominal compression was efficacious in 52% (95% CI 32.9–70.7) and
improved standing SBP (+10 mm Hg [95% CI 2–18]). Compression stockings were the least
efficacious therapy (32% [95%CI 16.1–51.4]) and had little effect on standing SBP (+6mmHg
[95% CI −1, 13]). No intervention improved symptoms during standing. There were no
adverse events.
Conclusions
Bolus water drinking should become the standard first-line nonpharmacologic intervention,
whereas compression stockings should be disregarded in this population.
Classification of evidence
This study provides Class III evidence that for older people with OH, bolus water drinking is
superior to other nonpharmacologic interventions in decreasing SBP drop.
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Orthostatic hypotension (OH) is a disabling condition, result-
ing from a sustained reduction in blood pressure (BP; ≥20 mm
Hg systolic or ≥10 mm Hg diastolic) within 3 minutes of
standing.1 Aging is one of the most common causes of neuro-
genic OH, affecting 7% to 30% of community-dwelling older
people.2 Clinical guidelines recommend nonpharmacologic
therapy as first-line treatment in OH, but older people are
typically excluded from research, creating a great deal of clinical
uncertainty.3 Because the older population is expanding rapidly,
we can expect a growing demand for evidence in this area.
Methods
Population
All participants were >60 years of age and had OH according
to international criteria.1 Dysautonomia was confirmed on
autonomic function testing and was judged to be secondary to
aging (in the absence of other identifiable causes). Exclusions
were dysphagia, fluid restriction, and inability to wear com-
pression garments. Participants were recruited via the UK
Clinical Trials Gateway and a Falls and Syncope Service in
Northeast England.
Setting
Procedures occurred between 9:30 and 11:30 AM in the Falls
and Syncope Service. Participants refrained from caffeine and
nicotine and ate a light breakfast only before attending.
Medications were withheld for ≥12 hours before attending.
Interventions
Selection of nonpharmacologic interventions was based on
a recent systematic review and recommendations of the Eu-
ropean Federation of Neurological Sciences3,4: bolus water
drinking (480 mL tap water consumed within 5 minutes),
physical countermaneuvers (standing cross-legged5), com-
pression stockings (to upper thigh [23–32 mm Hg]), and
abdominal compression (elastic belt).
Procedure
Visit 1
To establish a control BP profile, participants rested supine
for 10 minutes while undergoing continuous cardiovascular
monitoring (Task Force Monitor, CNSystems, Graz, Austria)
before standing upright for 3 minutes and noting symptoms.
Participants then ingested the water. After 20 minutes, the
orthostatic challenge was repeated.6
To estimate levels of frailty, dominant handgrip strength was
quantified with a hydraulic dynamometer (Jamar, Sammons
Preston Inc., Bolingbrook, IL). The Charlson Comorbidity
Index score was calculated to illustrate the cohort’s comorbidity.
Visit 2
A control orthostatic BP profile was established with the
aforementioned methods. Participants were randomized to
the order in which the interventions were administered by
selecting a sealed opaque envelope. An orthostatic challenge
(supine and standing BP) was repeated for each intervention
with a 20-minute washout period between the challenges.
Outcomes
The primary outcome was response rate to each intervention
(proportion of participants whose systolic BP drop improved
≥10 mm Hg). The secondary outcomes were nadir standing
systolic BP, BP drop, adverse events, and symptoms (Orthostatic
HypotensionQuestionnaire SymptomAssessment7: participants
rate the severity of 6 symptoms [dizziness/lightheadedness, vi-
sion, weakness, fatigue, trouble concentrating, head/neck dis-
comfort] from 0 to 10, from which an average score is derived
[maximum severity 10]; the Daily Activity Scale was not evalu-
ated because this is a longer-term measure of symptom impact).
Analysis
An exact, single-stage, phase 2 study design was used.8 The
study had 80% power to demonstrate a 30% response rate and
a 95% chance of rejecting interventions with response
rates ≤10%.
The mean and SD are displayed for normally distributed data;
median (range) is used for nonparametric data. Response
rates with 95% confidence intervals (CIs) were calculated
with the use of exact binomial methods. The paired t test and
Wilcoxon signed-rank test were used for statistical compari-
son of secondary outcomes using 2-sided p values.
Standard protocol approvals, registrations,
and patient consents
This study was approved by the UK National Research Ethics
Service (Newcastle and North Tyneside 2). All participants
gave written informed consent. The study was registered
prospectively with the UK Clinical Trials Gateway on Sep-
tember 12, 2015 (ISRCTN15084870).
Classification of evidence
The primary objective was to define the response rate to each
therapy. This study provides Class III evidence that for older
people with OH, bolus water drinking is superior to other
nonpharmacologic interventions in decreasing systolic BP drop.
Data availability
Anonymized data generated during the current study are
available from the corresponding author on reasonable re-
quest from individuals affiliated with research or health care
institutions.
Glossary
BP = blood pressure; CI = confidence interval; OH = orthostatic hypotension.
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Results
Twenty-five participants were recruited between January and
November 2016 (figure 1). Demographic and baseline data
are displayed in the table. The median grip strength is slightly
lower than UK age-adjusted population norms, suggesting
a degree of frailty.9 The effect of each intervention on standing
systolic BP is shown in figure 2. There were no adverse events.
No intervention had a significant impact on the specific
symptom of dizziness/lightheadedness (data available from
Dryad, table 1, doi.org/10.5061/dryad.h37j22d). Results for
the Orthostatic Hypotension Questionnaire Symptom As-
sessment subscale are provided below.
Bolus water drinking
Themedian volume of water consumed was 480mL (248–480
mL). Fourteen participants responded to bolus water drinking
(response rate 56%, 95% CI 37%–74%). Systolic BP drop was
significantly lower after water (33 [19] mm Hg, p = 0.021).
There was no effect on diastolic BP drop (15 [12] mmHg, p =
0.103) or on symptoms (1 [0–8], p = 0.923).
Physical countermaneuvers
Eleven participants responded to physical countermaneuvers
(response rate 44%, 95% CI 26%–63%). There was no effect
on systolic BP drop (35 [24] mm Hg, p = 0.085) or on
symptoms (2.2 [0–6.8], p = 0.117). However, diastolic BP
drop improved significantly (13 [16] mm Hg, p = 0.047).
Compression stockings
Eight participants responded to compression stockings (response
rate 32%, 95%CI 16%–51%, p = 0.002). There was no change in
systolic or diastolic BP drop (40 [21] mm Hg, p = 0.642 and18
[13]mmHg, p= 0.815, respectively) or in symptoms (0.8 [0–7],
p = 0.818).
Figure 1 Summary of participant screening and enrollment
BP = blood pressure.
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Abdominal compression
Thirteen participants responded to abdominal compression
(response rate 52%, 95% CI 33%–71%, p < 0.001). Systolic
BP drop reduced significantly (32 [18] mm Hg, p = 0.007),
but diastolic BP drop did not (15.3 [12] mm Hg, p = 0.192).
There was no change in symptoms (1.3 [0–6.3], p = 0.447).
Discussion
This study demonstrates that bolus water drinking is the most
efficacious nondrug therapy for aging-associated OH. Ab-
dominal compression and physical countermaneuvers also
resulted in reasonable response rates but had variable effects
on secondary cardiovascular outcomes. In contrast, full leg
length compression resulted in relatively low response rates
and had no effect on secondary outcomes. The absence of any
effect on symptoms is likely explained by a lack of power to
detect small changes in secondary outcomes. The median
symptom score was much higher during physical counter-
maneuvers, possibly due to the cardiovascular effects of
physical exertion such as vasodilation or possibly to a reduced
standing balance.
Because nonpharmaceutical interventions are recommended as
first-line therapy and are preferred by older people, it is essential
that we develop a robust evidence base for their use,4 particu-
larly in the context of the rapidly expanding older population.10
Furthermore, there are special considerations that are relevant
to older populations. Older people are more likely to have
coexisting problems (e.g., urinary incontinence, limited mo-
bility) that may limit the use of nondrug interventions. Com-
pression garments may also be limited by the difficulties of
applying and removing these single-handedly. If clinicians are to
recommend therapies when barriers exist, it is important that
the value of the intervention is known to aid patient education
and ultimately adherence.
This phase II study is relatively small, limiting its external
validity. Further evaluation is needed to explore the efficacy of
combined therapies and to establish long-term effectiveness.
Table Baseline characteristics
Demographic
Age, median (range), y 74 (60–92)
Male, n (%) 15 (60)
Charlson Comorbidity Index score, median (range) 4 (3–8)
Regular medications, median (range) 4 (0–13)
Fludrocortisone, n 5
Midodrine, n 3
Dominant hand grip strength, median (range), kg 25 (2–54)
Demographic Visit 1 Visit 2
Control supine BP, mean (SD), mm Hg
Systolic 128 (21) 126 (19)
Diastolic 75 (13) 77 (12)
Control standing BP nadir, mean (SD), mm Hg
Systolic 87 (26) 84 (25)
Diastolic 57 (13) 59 (16)
Control orthostatic BP drop, mean (SD), mm Hg
Systolic 41 (22) 41 (20)
Diastolic 19 (13) 18 (13)
Control orthostatic symptoms, OHSA score, median (range)
Composite symptom score 1 (0–8.5) 1.2 (0–6)
Dizziness 2 (0–9) 4 (0–9)
Abbreviations: BP = blood pressure; OHSA = Orthostatic Hypotension Questionnaire Symptom Assessment subscale.
Control indicates values derived from baseline postural BP measurement before intervention. Maximum OHSA score is 10; maximum dizziness score is 10.
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It is important to note that in each case, the control ortho-
static BP was performed first, closer in time to any preceding
meal. This could have exerted greater postprandial hypoten-
sive effects on the control BP compared to the interventions,
exaggerating the beneficial effects of the interventions.
Bolus water drinking should become the standard first-line
nonpharmacologic intervention, whereas compression
stockings should be disregarded in this population.
Author contributions
J.L.N.: study concept, data interpretation, manuscript prepa-
ration. J.F.: study concept and design, data collection, analysis
and interpretation, statistical analysis, and manuscript
preparation.
Study funding
No targeted funding reported.
Disclosure
Dr. Newton: has received research funding from UKNational
Institute for Health Research Efficacy and Mechanism Eval-
uation, Arthritis Research UK, ME Research UK and Action
for ME. Dr. Frith: This report is independent research arising
from a Clinician Scientist Award (CS-2014-14-002) sup-
ported by the UKNational Institute for Health Research. The
views expressed in this publication are those of the authors
and not necessarily those of the UK NHS, the National In-
stitute for Health Research, or the Department of Health. Dr.
Frith has also received research funding from The Dowager
Countess Eleanor Peel Trust. Go to Neurology.org/N for full
disclosures.
Received November 23, 2017. Accepted in final form May 11, 2018.
References
1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of
orthostatic hypotension, neurally mediated syncope and the postural tachycardia
syndrome. Clin Auton Res 2011;21:69–72.
2. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res 2008;18:8–13.
3. Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic management of
orthostatic hypotension: a systematic review. Arch Phys Med Rehabil 2015;96:
366–375 e366.
4. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guide-
lines on the diagnosis and management of orthostatic hypotension. Eur J Neurol
2006;13:930–936.
5. Wieling W, van Dijk N, Thijs RD, de Lange FJ, Krediet CT, Halliwill JR. Physical
countermeasures to increase orthostatic tolerance. J Intern Med 2015;277:69–82.
6. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in
humans: a sympathetic reflex? Circulation 2000;101:504–509.
7. Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The Ortho-
static Hypotension Questionnaire (OHQ): validation of a novel symptom assessment
scale. Clin Auton Res 2012;22:79–90.
8. A’Hern RP. Sample size tables for exact single-stage phase II designs. Stat Med 2001;
20:859–866.
9. Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: nor-
mative data from twelve British studies. PLoS One 2014;9:e113637.
10. Frith J, Elliott CS, Bashir A, Newton J. Public and patient research priorities for
orthostatic hypotension. Age Ageing 2014;43:865–868.
Figure 2 Change in standing systolic BP
Change in standing systolic blood pressure (BP) with each intervention compared to no intervention. Control refers to the difference between the baseline
postural BP assessments on visits 1 and 2. CI = confidence interval; PCM = physical countermaneuver.
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